Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sanhanhuashi
- Development stage
- Unknown
- Lead developer
- Hospital Affiliated to Changchun University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Sanhanhuashi (also known as Sanhan Huashi Granules) is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of COVID-19. It was formulated based on the Wuhan Cold-Dampness Formula (Wuhan Kangyi Fang) by a team led by Academician Tong Xiaolin. The preparation is designed to dispel cold, eliminate dampness, and detoxify, specifically targeting the cold-dampness pestilence syndrome observed in patients during the early stages of the pandemic. In November 2022, the China National Medical Products Administration (NMPA) granted marketing authorization for Sanhanhuashi granules for the treatment of mild and moderate COVID-19 cases presenting with symptoms such as fever, cough, and fatigue. The formula consists of multiple botanical ingredients that work synergistically to modulate the immune response and alleviate respiratory symptoms.
- Brand names
- Sanhanhuashi
- Other names
- Sanhan Huashi Granules散寒化湿颗粒Wuhan Cold-Dampness FormulaWuhan Kangyi Fang
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))Mpro (3C-like proteinase of SARS-CoV-2)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on sanhanhuashi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sanhanhuashi.